Skip to main content
. 2020 Jun 16;20:167. doi: 10.1186/s12866-020-01855-y

Table 1.

Antimicrobial resistance pattern, antibiotic resistance genes, virulence genes, capsular type and sequence type of isolates

Isolate Resistance MIC (μg/ml) Tn Virulence Factor Genes Capsular type ST
Phenotype genes P E T
1 CD, E, Oxa, T, TS ermB, mefA/E, tetM ≥256 ≥256 24 cbpA, cpsA, lytA 11A 9533
2 Oxa, TS tetM 0.75 ND ND cbpA, cpsA, lytA, ply, pspA
3 CD, E, Oxa, T, TS ermB, tetM 1.5 ≥256 16 cbpA, cpsA, lytA, ply, pspA 19A 15,139
4 Oxa, TS mefA/E 0.094 ND ND cbpA, cpsA, lytA, ply, pspA 12,224
5 CD, E, Oxa, T, TS ermB, mefA/E, tetM 48 ≥256 12 cbpA, cpsA, lytA 11A 9533
6 CD, E, Oxa, T, TS ermB, mefA/E, tetM 48 ≥256 16 cbpA, cpsA, lytA, ply 15B/C
7 CD, E, Oxa, T, TS ermB, mefA/E, tetM 0.19 ≥256 8 cbpA, cpsA, lytA, ply, pspA 19A
8 CD, CLR, E, Oxa, T, TS ermB, mefA/E, tetM 48 ≥256 16 cbpA, cpsA, lytA, ply 23F 15,140
9 CD, CLR, E, Oxa, T, TS ermB, tetM 48 ≥256 16 cbpA, cpsA, lytA, ply, pspA 23F
10 CD, CLR, E, Oxa, T, TS ermB, tetM 1.5 ≥256 8 cbpA, cpsA, lytA, ply, pspA 23F
11 Oxa, T, TS tetM 1 ND 4 cbpA, cpsA, lytA, ply, pspA 15A
12 E, Oxa, TS mefA/E 0.125 8 ND cbpA, cpsA, lytA, ply, pspA 14
13 CD, CLR, E, Oxa, T, TS ermB, mefA/E, tetM 32 ≥256 24 cbpA, cpsA, lytA, ply, pspA 23F
14 E, Oxa, TS mefA/E 1 12 ND cbpA, cpsA, lytA, ply 6A/B
15 Oxa, TS 0.38 ND ND cbpA, cpsA, lytA, ply 6A/B
16 CD, E, Lvo, Oxa, T, TS ermB, tetM 0.5 ≥256 8 cbpA, cpsA, lytA, ply 19A
17 TS 1 ND ND cbpA, cpsA, lytA, ply 15A
18 CD, CLR, E, Oxa, T, TS ermB, tetM 2 ≥256 12 6002 cbpA, cpsA, lytA, ply 23F
19 E, TS, Oxa mefA/E 0.047 2 ND cbpA, cpsA, lytA, ply, pspA 6A/B
20 E, CD, T, Oxa, TS ermB, tetM 0.5 ≥256 12 6002 cbpA, cpsA, lytA 15A
21 E, Oxa, TS ermB, mefA/E 0.19 3 ND cbpA, cpsA, lytA 15B/C 1888
22 CD, E, Oxa, T, TS ermB, tetM 0.5 ≥256 8 6002 cbpA, cpsA, lytA 15A
23 Oxa, TS tetM 1.5 ND ND cbpA, cpsA, lytA, pspA 15A
24 E, Oxa, T, TS mefA/E, tetM 0.5 12 12 2009 cbpA, cpsA, lytA, ply 9 V
25 Oxa, T tetM 1.5 ND 8 916 cbpA, cpsA, lytA, pspA 1
26 E, Oxa, T, TS, mefA/E, tetM 16 2 24 2009 cbpA, cpsA, lytA 19A 1339
27 CD, E, Oxa, T, TS ermB, tetM 0.38 ≥256 16 cbpA, cpsA, lytA, ply, pspA 14
28 Oxa, TS 1 ND ND cbpA, cpsA, lytA, ply 6A/B
29 CD, CLR, E, Oxa, T, TS ermB, tetM 2 ≥256 24 6002 cbpA, cpsA, lytA, ply 23F
30 CD, E, Oxa, T, TS ermB, tetM 1 24 16 cbpA, cpsA, lytA, ply 19F
31 E, Oxa, TS mefA/E 0.75 3 ND cbpA, cpsA, lytA, ply, pspA 6A/B
32 CD, E, T, TS ermB, tetM 0.094 4 8 3872 cbpA, cpsA, lytA, ply 19A 12,888
33 CD, E, T, TS ermB, tetM 0.38 12 24 6002 cbpA, cpsA, lytA, ply 6A/B
34 E, Oxa, TS mefA/E 0.75 4 ND cbpA, cpsA, lytA, ply 9 V
35 E, Oxa, TS mefA/E 0.094 4 ND cbpA, cpsA, lytA, ply 6A/B
36 Oxa mefA/E 0.75 ND ND cbpA, cpsA, lytA 19A
37 Oxa, T, TS tetM 0.75 ND 8 916 cbpA, cpsA, lytA, ply
38 Oxa, T, TS ermB, tetM 0.5 ND 4 6002 cbpA, cpsA, lytA, ply 15A
39 Oxa, T, TS tetM 4 ND 8 916 cbpA, cpsA, lytA, ply 19A
40 E, Oxa, T ermB, mefA/E, tetM 1 3 16 1545/6003 + MEGA cbpA, cpsA, lytA, pspA 11A
41 E, Oxa, T ermB, mefA/E, tetM 0.75 2 16 1545/6003 + MEGA cbpA, cpsA, lytA, pspA 11A
42 E, Oxa, T mefA/E, tetM 0.094 3 48 2009 cbpA, cpsA, lytA, pspA 15A
43 CD, E, Oxa, T, TS ermB, mefA/E, tetM 0.75 ≥256 6 2010 cbpA, cpsA, lytA, ply 19F 2533
44 E, Oxa mefA/E 0.19 4 ND cbpA, cpsA, lytA, ply, pspA 6A/B 1876

CD clindamycin, CLR chloramphenicol, E erythromycin, Lvo levofloxacin, Oxa oxacillin, P penicillin, T tetracycline, TS trimethoprim/sulfamethoxazole, ND non-determined, Tn transposon, ST sequence type

MIC Breakpoints: Penicillin: S ≤ 2; I = 4; R ≥ 8, Tetracycline: S ≤ 1; I = 2; R ≥ 4, Erythromycin: S ≤ 0.25; I = 0.5; R ≥ 1